Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia
Launched by PICTERUS AS · Nov 18, 2022
Trial Information
Current as of July 23, 2025
Terminated
Keywords
ClinConnect Summary
A cross-sectional conductive study aiming to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at Airlangga University hospital and RSIA Kendangsari MERR in Surabaya.
This cross-sectional study evaluates the accuracy of a novel smartphone application that estimates bilirubin levels in Indonesian newborns. The Picterus Calibration Card was placed on the chest of the newborn with the hole in the card placed over the infant's sternum. A validated smartphone with Picterus JP was used to collect digital images.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants born with gestational age \>31
- • Birth weight ≥ 1500g
- • Age 0 - ≤14 days
- • Consent obtained from the parents
- Exclusion Criteria:
- • Infants born with congenital abnormalities;
- • Infants respiratory support;
- • Infants suffering from a condition that may alter the skin tissue circulatory system, such as sepsis and heart failure;
- • Infants who have received phototherapy in the last 24 hours.
About Picterus As
Picterus AS is an innovative clinical trial sponsor dedicated to advancing medical research through the development of cutting-edge imaging technologies. Specializing in the integration of artificial intelligence and machine learning with diagnostic imaging, Picterus AS aims to enhance the accuracy and efficiency of clinical trials. By leveraging state-of-the-art methodologies and a commitment to patient-centered outcomes, the company seeks to optimize the drug development process and improve therapeutic interventions across various healthcare sectors. With a focus on collaboration and scientific rigor, Picterus AS is positioned to make significant contributions to the future of medical diagnostics and treatment efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Surabaya, East Java, Indonesia
Surabaya, East Java, Indonesia
Surabaya, East Java, Indonesia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials